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Abstract
Background: Mutations of human aA-crystallin cause congenital cataract by protein aggregation. How mutations of aA-
crystallin cause disease pathogenesis through protein aggregation is not well understood. To better understand the cellular
events leading to protein aggregation, we transfected cataract causing mutants, R12C, R21L, R21W, R49C, R54C, R116C and
R116H, of human aA-crystallin in HeLa cells and examined the formation of intracellular protein aggregates and aggresomes
by confocal microscopy.
Methodology/Principal Findings: YFP-tagged human aA-wild-type (aA-wt) was sub-cloned and the mutants were
generated by site-directed mutagenesis. The aA-wt and the mutants were individually transfected or co-transfected with
CFP-tagged aA-wt or aB-wild-type (aB-wt) in HeLa cells. Overexpression of these mutants forms multiple small dispersed
cytoplasmic aggregates as well as aggresomes. Co-expression of aB-wt with these mutants significantly inhibited protein
aggregates where as co-expression with aA-wt enhanced protein aggregates which seems to be due to co-aggregation of
the mutants with aA-wt. Aggresomes were validated by double immunofluorescence by co-localization of c-tubulin, a
centrosome marker protein with aA-crystallin. Furthermore, increased ubiquitination was detected in R21W, R116C and
R116H as assessed by western blot analyses. Immunostaining with an ubiquitin antibody revealed that ubiquitin inclusions
in the perinuclear regions were evident only in R116C transfected cells. Pulse chase assay, after cycloheximide treatment,
suggested that R116C degraded faster than the wild-type control.
Conclusions/Significance: Mutants of aA-crystallin form aggregates and aggresomes. Co-expression of aA-wt with the
mutants increased aggregates and co-expression of aB-wt with the mutants significantly decreased the aggregates. The
mutant, R116C protein degraded faster than wild-type control and increased ubiquitination was evident in R116C
expressing cells.
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Introduction
Cataract of the eye lens is the leading cause of blindness
worldwide [1]. Pediatric cataract of the congenital type is the most
common form of childhood blindness and it is clinically and
genetically heterogeneous. About 30-50% of all bilateral pediatric
cataracts have a genetic basis [2]. All three forms of Mendelian
inheritance have been observed, the most frequently observed type
seen in non-consanguineous population being the autosomal
dominant transmission. At least 34 loci in the human genome have
been reported to be associated with various forms of pediatric
cataracts. Autosomal dominant and recessive forms of cataracts
have been caused by mutations in 22 different genes [2]. More
than half of the mutations occur in crystallins (a-, b-, and c-
crystallins) and the remaining in connexins, intrinsic membrane
proteins and intermediate filament proteins. Most interestingly, a
total of 12 mutants belong to a-crystallin, 8 for aA-crystallin and 4
for aB-crystallin., it points to a major role a-crystallin mutants play
in the development of congenital cataracts.
The a-crystallin gene family consists of two similar genes coding
for aA-crystallin, CRYAA located on chromosome 21q22.3, and
for aB-crystallin, CRYAB located on chromosome 11q22.1 [3].
The first exon of each gene encodes 60 amino acids consisting
of a repeat of 30 amino acid motif and the second and the third
exons code for regions homologous for the sHsps [4]. Three aA-
crystallin missense mutations have been reported recently which
are: base 104 C.T (R12C), base 130 C.T (R21W) and base 230
C.T (R54C) [5]. The affected members of the three families had
autosomal dominant bilateral congenital nuclear cataract in
association with microcornea, all detected at the time of birth.
Affected members of one of this family (R21W) were also
diagnosed with microphthalmia. R12C and R21W cases showed
zonular opacification with varying involvement of the anterior and
posterior pole. It is noteworthy that these mutations occurred
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9outside the a-crystallin/sHsp core domain. Moreover, the
arginines at positions 12, 21, and 54 are highly conserved in
aA-crystallin. The other aA mutants reported earlier with
autosomal dominant congenital cataracts are: R21L [6], R49C
[7], G98R [8], R116C [9] and R116H [10].
A recent report [11] on the biophysical as well as the
hydrodynamic properties of the mutants of aA-crystallin have
prompted us to further investigate the actual mechanism by which
these mutations can lead to early onset of cataract. In all the seven
mutants, arginine residues were mutated to mostly cysteine, leucine,
tryptophan or histidine. In this study [11], the quaternary structural
parameters (hydrodynamic properties) were determined by dynam-
ic light scattering measurements. As compared to aA-wt, average
molar mass, polydispersity, and hydrodynamic radius increased
several fold in R116C and R116H, moderately increased in R12C,
R21W, and R54C, and not increased in R21L and R49C. With
regard to secondary and tertiary structural changes, all the mutants
showed varying degree of secondary and tertiary structural changes,
R21W, R116C, and R116H consistently showing the largest
changes. Such changes can lead to protein unfolding/misfolding
and subsequently forming protein aggregates.
Since mutants of aA-crystallin contribute to the development of
congenital cataract through the formation of aggregated proteins
precipitated in the cells of eye lens, we evaluated the expression of
mutants of aA-crystallin in mammalian cells (HeLa cells) in terms of
identifying the cells having aggregates and aggresomes as the general
cellular response to having over expressed mutant proteins [12].
Aggresomes are thought to immobilize protein aggregates and render
them susceptible to proteolysis by a component known as protea-
somes and/or autophagy [13]–[15]. In view of the propensity of aA-
crystallin mutants to aggregate in cells, we also explored whether
there is any involvement of ubiquitin-proteasomal pathway (UPP)
contributing to the degradation of unfolded proteins of mutants of
aA-crystallin. The ubiquitin-proteasome system (UPS) plays an
essential role in degrading damaged or unfolded proteins [16].
Unfolded proteins and protein fragments generated by proteolysis are
polyubiquitinated by ubiquitin ligases, a process that targets the
substrate proteins to the proteasome for degradation [17]. The 26S
proteasome which consists of a catalytic 20S core particle and a 19S
regulatory particle selectively degrades ubiquitinated proteins [18];
our results suggest that the mutants,R21W, R116C and R116H have
elevated polyubiquitinated species.
Materials and Methods
Site directed mutagenesis
To generate mutants, QuickChange site directed mutagenesis
kit (Agilent Technologies Inc, CA) was used. Appropriate
mutagenic primers of human aA-crystallin for the mutants,
R12C, R21L, R21W, R49C, R54C, R116C and R116H were
designed and used for PCR. The PCR products were amplified by
using YFP-tagged aA-wt as a template DNA with the following
PCR conditions, the mix was initially denatured at 95uC for 1 min
followed by 95uC for 50 sec, 60uC for 50 sec and 68uC for 5
minutes for 16 cycles and followed by overall extension at 68uC for
7 minutes. The PCR product was digested with Dpn I for 1 hour at
37uC and 1 ml of PCR product was transformed with XL-10 Gold
competent cells. The transformants were selected on LB agar
medium plates containing 50 mg/ml Kanamycin. The mutant
constructs were sequenced and confirmed by DNA sequence
analysis. Untagged pCDNA3.1-aA-wt and the mutant R116C
were PCR amplified from appropriate cDNA templates and
sub-cloned into Xho I and Eco RI sites of pCDNA3.1 (-) vector
(Invitrogen, CA). The constructs were validated by restriction
digestion and DNA sequence analyses.
Cell culture and transfection
HeLa cells purchased from ATCC, Manassas, VA were grown in
35 mm dishes and 80–90% confluent cells were transfected with
Lipofectamine 2000 (Invitrogen, CA) and a total of 2 mg of plasmid
DNA encoded for aA-wt and aB-wt and or mutated constructs fused
with either CFP or YFP were used. In one set of experiments,
individual constructs for aA-wt and the mutants and for co-
expression studies, equal amount of both aA-wt and aB-wt with
mutated aA constructs were transfected. Transfected cells showing
aggregates were typically counted at x40 magnification. Fields were
randomly chosen and about 300 cells were counted per experiment
and repeated at least three times and counts were blindly performed.
Laser scanning confocal microscopic studies
An LSM 510 Laser Scanning Microscope (Carl Zeiss Inc.,
Thornwood, NY) with 63x oil-immersion objective (plan Apoc-
hromat, NA 1.4) (University of Arkansas for Medical Sciences core
facility) was utilized. To visualize CFP and YFP fluorescence, cells
expressing fluorescent proteins were excited at appropriate laser
beam and filtered with both dichromatic band pass filters, captured
at 12 bit 512 x 512, multitrack channel images with CCD cameras
with the following configurations: for CFP channel, the cells were
excited with 458 nm filter by argon-ion laser and the emission
intensity was collected using band pass (BP) 475-525 nm filters and
for YFP channel, the cells were excited with 514 nm filter by argon-
ion laser and the emission intensity was collected using BP 530–
600 nm filters. Both the CFP and YFP was excited using argon-ion
laser at 25 mW, 2.0 and 0.5% exposure respectively.
Cycloheximide chase assay
Degradation of aA wild-type and the mutant aA-R116C
proteins was assessed using cycloheximide-chase assay. HeLa cells
were grown in 35 mm dishes and transfected with untagged aA-wt
and the mutant R116C. After 24 h transfection, cells were treated
with 20 mg/mL of cycloheximide (Sigma) for the indicated time
period and lysed with lysis buffer containing 50 mM Tris-HCl
(pH 7.4), 150 mM NaCl, 0.02% sodium azide, 0.1% SDS, 1%
NP-40, 0.5% sodium deoxycholate and 0.1 mM EDTA supple-
mented with cock-tail protease inhibitors (Roche Diagnostics) and
3M Urea. For immunoblot analysis, 5 mg of total protein was
loaded into 12% SDS-PAGE and the western blot was probed
with a rabbit polyclonal anti-aA-crystallin antibody (Enzo Life
Sciences Inc, SPA-221) at a dilution of 1 in 6000.
SDS-PAGE and Western blot analysis
After 48 hours transfection, cells were lysed with lysis buffer
containing 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.02%
sodium azide, 0.1% SDS, 1% NP-40, 0.5% sodium deoxycholate
and 0.1 mM EDTA supplemented with cock-tail protease
inhibitors and 3M Urea. Further, the cell lysate was sonicated
and the protein concentration was measured by BCA assay
method. For each sample, 5 mg of total protein was loaded into
12% SDS-PAGE and electroblotted to PVDF membrane. The
blots were blocked with 5% non-fat dry milk prepared in TBST
(Tris-buffered saline supplemented with 0.1% Tween 20) and
subsequently incubated with primary antibody for aA-crystallin
(monoclonal, Abcam, ab78439, 1:2000), aB-crystallin (rabbit
polyclonal, Abcam, ab13497, 1:2000) for one hour at room
temperature. Blots were washed with TBST for three times and
incubated with appropriate HRP-conjugated secondary antibodies
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room temperature. Enhanced Chemiluminescence substrate was
used and the signal was detected by exposing the blots on films.
For loading control, blots were stripped with Restore Western Blot
stripping buffer (Thermo Scientific Inc, IL) and re-probed with a
rabbit polyclonal antibody against b-actin (Abcam, ab8227,
1:10000) for 1 hour at room temperature.
Immunofluorescence microscopy for aggresome detection
Cells were grown on 35-mm cover glass bottom dishes. After
48 hours transfection, cells were washed with PBS, fixed with 4%
paraformaldehyde for 20 minutes at room temperature (RT) and
permeabilized with 0.5% Triton X-100 for 10 minutes at RT. Cells
were blocked with 5% normal goat serum (NGS) for one hour at
RT. The cells were simultaneously incubated with aA-crystallin
mouse monoclonal antibody (1 in 200 in 5% NGS, Abcam,
ab78439) and a rabbit polyclonal antibody for c-tubulin (Abcam,
ab16504; 1 in 200 dilution in 5% NGS) for overnight at 4uC. The
cellswerestainedwithAlexaFlour594(mouse)and AlexaFluor488
(rabbit) (Molecular Probes) for one hour at room temperature.
Nuclei were counter stained with Hoechst 33342. The images were
acquired with an LSM 510 Meta Carl Zeiss Confocal microscope at
x63 objective and analyzed using AIM Imaging Software.
Data Analysis and Statistics
In all the experiments, values were expressed as mean 6 SD.
Two-tailed Student’s t-test was used for statistical analysis. The
p value , 0.05 was considered as significant.
Figure 1. YFP-aA-wt and the mutant constructs, R12C, R21L, R21W, R49C, R54C, R116C and R116H were individually expressed in
HeLa cells. A: LSM Images were captured after 48 hours transfection. HeLa cells were individually transfected with 2 mg of YFP-tagged aA-wt and
mutants of aA-crystallin. A homogenous expression of aA-crystallin was evident in aA-wt transfected cells. Cytoplasmic aggregates were evident in
aA- crystallin mutants transfected cells. The YFP signal was excited at 514 nm and the images were collected by BP 530-600 nm filter. The images
represent one of the four similar images obtained in three independent experiments. B: Graph represents per cent of cells with aggregates. The results
obtained after 48 hours transfection for the individually expressed aA-wt or its mutants in HeLa cells. Cells containing aggregates were counted in 10
random fields each field with 30 cells. The mutant, R116C showed a high per cent (,47) of cells having aggregates and the mutant R21L showed least
per cent (,10) of cells containing aggregates. The results were presented as means 6 SD obtained in three independent experiments. All the
mutants were statistically significant, p , 0.01.
doi:10.1371/journal.pone.0028085.g001
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Individual expression of YFP-tagged aA-crystallin wild-
type and mutants in HeLa cells
To investigate whether the mutants of aA-crystallin forms
aggregates in cells, YFP-tagged wild-type and the mutants of aA-
crystallins were transfected individually in HeLa cells. Cells
transfected with CFP or YFP alone showed a homogenous
expression of the fluorescent protein in both nucleus and
cytoplasm (data not shown). Cells transfected with aA-wt showed
a homogenous distribution of its expression in the cytoplasm alone
and there was a little or no aggregation was observed in these cells
(Fig. 1A). Cells transfected with the mutants, R12C, R21L, R21W,
R49C, R54C, R116C, R116H showed significant number of
cells having protein aggregates, 37.263.8, 10.562.6, 30.264.7,
24.561.1, 18.563.1, 4765.8, 28.163.4 (Fig. 1B) respectively.
Here, the intracellular aggregation is referred to as the clumped
particles predominantly localized in the cytoplasm. Cells contain-
ing more than three such particles were considered as positive for
cells having aggregates and scored in this assay. Moreover, the
morphology of cells was altered in cells expressing R21W and
R116C mutants (Fig. 1A).
Co-expression of CFP-aA-wt and YFP-tagged mutants of
aA-crystallins
To investigate whether co-expression of aA-wt can inhibit
aggregates caused by mutants of aA-crystallin in cells, we
transfected YFP-tagged aA-mutants with CFP-tagged aA-wt.
Co-expression of CFP-aA-wt with YFP-aA-wt constructs in HeLa
cells did not show any aggregates and a homogenous expression of
Figure 2. YFP-aA-wt and its mutants were co-expressed with CFP-tagged aA-wt. A: Laser scanning confocal microscope images. HeLa cells
were transfected with 1 mg each of CFP-tagged aA-wt and YFP-tagged mutant constructs. After 48 h transfection, cells were analyzed with confocal
microscope. Cells showed more aggregates when co-expressed with aA-wt. The CFP signal was excited at 458 nm and the images were collected by
BP 475–525 nm filter, YFP was excited at 514 nm and the images were collected by BP 530–600 nm filter. The images represent one of the four
similar images obtained in three independent experiments. B&C: Graph represents per cent of cells with aggregates. Cells were transfected with YFP-
tagged aA-wt or mutants and CFP-tagged aA-wt. Cells having aggregates were counted in 10 random fields each field with 30 cells after 48 h
transfection. The results were presented as means 6 SD obtained in three independent experiments. For aA-wt + aA-R12C: p , 0.03; for aA-wt + aA-
R21L : , 0.05; for aA-wt + aA-R21W : , 0.04, for aA-wt + aA-R49C, is not significant; for aA-wt + aA-R54C : , 0.0001; for aA-wt + aA-R116C : , 0.01
and for aA-wt + aA-R116H, is not significant.
doi:10.1371/journal.pone.0028085.g002
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co-expression with the mutants, R12C and R54C showed a few
nuclear foci. Cells co-expressed with all the other mutants except
R21L and R116H significantly increased the number of cells
having aggregates. The proportion the cells with aggregates were
53, 15, 51, 35, 40, 68 and 30% in mutants, R12C, R21L, R21W,
R49C, R54C, R116C and R116H respectively (Fig. 2B&C). Cells
co-expressed with R12C, R49C and R116C distorted the cellular
morphology (Fig. 2A). It is possible that the increase in the percent
of cells having aggregates in the mutants expressing cells was due
to co-aggregation with native aA-wt.
Co-expression of CFP- tagged aB-wt and YFP-tagged
mutants of aA-crystallin
To investigate, whether aB-wt co-expression can inhibit protein
aggregates caused by mutants of aA-crystallin, cells were
transfected with CFP-aB-wt and YFP-tagged aA-crystallin mu-
tants.. The results indicate that a significant decrease (52–72%, as
compared to the data in Fig. 2) of the number of cells having
aggregates was observed in cells transfected with all the mutants
but it is not statistically significant with the mutants, R21L and
R54C. Specifically, the mutants, R12C, R21W, R116C and
R116H showed the largest effect (61–72%) (Fig. 3A, B, C). Thus,
Figure 3. YFP-tagged aA-wt and each of the mutated aA-crystallin co-expressed with CFP-aB-wt. A: LSM images of HeLa cells after 48 h
transfection. HeLa cells were transfected with 1 mg each of CFP-tagged aB-wt and YFP-tagged aA-wt and the mutants. After 48 h transfection, images
were captured with an LSM confocal microscope. The CFP signal was excited at 458 nm and the images were collected by BP 475–525 nm filter, YFP
was excited at 514 nm and the images were collected by BP 530–600 nm filter. Co-expression of aB-wt significantly inhibited aggregates in cells
transfected with the aA- mutants. Images represent one of the four similar images obtained in three independent experiments. B&C: Graph represents
per cent of cells containing aggregates. The results obtained after 48 h transfection. Cells containing aggregates were counted in 10 random fields
each field with 30 cells. In all mutants, co-expression of aB-wt except with R21L and R54C significantly decreased the number of cells having
aggregates. The results were presented as means 6 SD obtained in three independent experiments. The p value for aB-wt + aA-R12C is , 0.02; for
aB-wt + aA-R21L is not significant; for aB-wt + aA-R21W is , 0.05; for aB-wt + aA-R49C is , 0.02; for aB-wt + aA-R54C is not significant, for aB-wt +
aA-R116C is , 0.01 and for aB-wt + aA-R116H is , 0.001.
doi:10.1371/journal.pone.0028085.g003
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aggregates. These results strongly suggest that aB-wt is a potential
chaperone to protect the cells from aggregates caused by the aA-
mutants.
Validation of the expression of CFP or YFP-tagged aA-wt
and/or aB-wt with mutants of aA-crystallin in HeLa cells
To validate that there was no discrepancy in the transfection
efficiency of the either individually transfected or co-transfected
with aA-wt and or aB-wt, total cell lystate were subjected to
immunoblot and probed with aA and or aB-crystallin antibodies.
A similar level of expression was detected in individually expressed
aA-wt or mutant constructs (Fig. 4A). The level of expression was
nearly equal in mutants co-expressed with aA-wt (Fig. 4B) and aB-
wt constructs (Fig. 4C).
Mutant aA-crystallins in HeLa cells form aggresomes
To demonstrate whether the large perinuclear structures are
aggresomes as seen in the cells transfected with the mutants,
R21W, R116C and R116H (three major aggregate forming
mutants) and to validate these inclusions as aggresomes,
transfected cells were subjected to double immunostaining with a
mouse monoclonal aA-crystallin (red) and rabbit polyclonal c-
tubulin, (a centrosome marker protein) (green) antibodies. For this
study, untagged pCDNA3.1 constructs of both wild-type and the
mutants R116C (severely affected cells) and R21L (mildly affected
cells) were used in order to eliminate the false positive signal by
overlapping of YFP signal with the Alexa Fluor 488, both of these
signals being acquired at argon-ion laser line in confocal
microscopy. The results showed that only in R116C, the co-
localization of aA-crystallin with c-tubulin occurred as yellow
punctate signals in the perinuclear region validated these
structures are aggresomes (Fig. 5) whereas, there were no
aggresomes in R21L expressing cells (Fig. 5).
Degradation of aggregate-prone aA-crystallin mutants
Since our finding that mutants of aA-crystallin form intracel-
lular aggregates in cells and this aggregate formation may affect
protein turn over which may contribute to the pathogenesis of the
cataract, we next asked whether mutation in aA-crystallin may
affect protein’s turn over by faster degradation, cells were treated
with cycloheximide (for inhibition of protein synthesis) and at
different time points. After 24 h transfection, the cells lysed and a
total protein of 5 mg from each of the sample was subjected to
immunoblot probed with aA-crystallin antibody (rabbit polyclon-
al, Enzo Life Sci, SPA-221). For this study, we used untagged
constructs of aA, i.e. pCDNA3.1/aA-wt and pCDNA3.1/aA-
R116C. As shown in Fig. 6A and Fig. 6B, pulse chase experiments
Figure 4. Western blot analysis of aA-crystallin-wt and its mutants, R12C, R21L, R21W, R49C, R54C, R116C and R116H expressed in
HeLa cells. A. Western blot analysis of HeLa cells individually expressed with aA-Crystallin: Cells were individually transfected with YFP-tagged aA-wt
and mutants. After 48 h transfection, cells were lysed and 5 mg of total protein was subjected to western blot. The blot was probed with human anti-
aA antibody. The same blot was stripped and re-probed for b- actin to serves as a loading control. Nearly a similar level of expression of aA was
evident in each of the transfected cells. The * indicates the non-speficific band. B: Western blot analysis of HeLa cells co-expressed with CFP-tagged aA-
wt and YFP-tagged aA-wt or its mutants. Cells were co-transfected with YFP-tagged aA-wt and mutants with CFP-tagged aA-wt. After 48 h
transfection, cells were lysed and 5 mg of total protein was subjected to western blot. The blot was probed with an antibody against human aA and
the same blot was stripped and re-probed for actin. A similar level of expression of aA was detected in each group. C: Western blot analysis of HeLa
cells co-expressed with CFP-tagged aB-wt and YFP-tagged aA-wt or its mutants. After 48 h transfection, 5 mg of total protein was subjected to western
blot. The blot was probed with an antibody against human aA and the same blot was stripped and re-probed for anti-aB. The same blot was again
stripped with anti-b-actin for loading control. The level of both aA and aB were nearly equal in each of the transfected cells.
doi:10.1371/journal.pone.0028085.g004
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protein is stable at least for 24 h. But the level of the mutant
protein R116C decreased to 75.663.2%, 5365.5%, and
51.362.5% compared to control after 6, 12 and 24 h of treatment
respectively (Fig. 6C and 6D) As expected the mutant protein has
lower half-life and degraded faster than the wild-type protein.
Accumulation of polyubiquitinated conjugates in
aA-crystallin mutants
A number of reports implicated UPS dysfunction in a range of
aggregation prone mutant proteins in neurodegenerative diseases.
To explore any effects of aggregation-prone aA-crystallin mutants
might have on UPS proteolytic function, we measured the level of
polyubiquitinated proteins in whole cell lysate subjected to western
blot probed with anti-ubiquitin antibody (FK2, Mouse Monoclo-
nal, Enzo Life Sciences, PW8810). Distinct polyubiquitin conju-
gated proteins accumulated in cells transfected with mutants,
R21L, R21W, R116C and R116H (Fig. 7, lanes 3, 4, 7 and 8). In a
separate experiment, to further show ubiquitin inclusions in
transfected cells, cells were subjected to immunostaining with a
mouse monoclonal ubiquitin antibody (FK2; Enzo Life Sci.Inc.,
PW 8810). The ubiquitin inclusions in the perinuclear regions
Figure 5. Detection of Aggresomes: Untagged pCDNA3.1 constructs of aA-wt and the mutants, R21L and R116C were used in this
study and compared. After 48 h transfection, cells were fixed, permeabilized with 0.5% Triton X-100 and double immunostained with a mouse
monoclonal aA-crystallin (red) antibody and a rabbit polyclonal antibody for c-tubulin (green). A strong degree of overlapping signal (yellow) was
evident only in R116C transfected cells (arrow). Co-localization of c-tubulin, a centrosome maker protein with aA-crystallin in the perinuclear region
validated these inclusions were aggresomes. There was no co-localization in cells transfected with either aA-wt or the mutant, R21L. Goat anti-mouse
Alexa Fluor 594 (red) antibody was used to stain and visualize the localization of aA-wt and the mutants, R21L and R116C. A rabbit secondary
antibody, Alexa Fluor 488 (green) was used to stain and visualize the c-tubulin. The nuclear stain Hoechst was used to counter stain the nuclei. The
images were representative of one of four such images obtained in three independent experiments.
doi:10.1371/journal.pone.0028085.g005
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Altogether, these results suggest that mutants of aA-crystallin
proteins were conjugated with ubiqutin for degradation.
Discussion
In the present study, we have demonstrated that overexpression
of the cataract causing mutants of aA-crystallin in HeLa cells led
to the formation of multiple intracellular protein aggregates. There
was no evidence for the endogenous expression of both aA- and
aB-crystallins in these cells as shown in our earlier study [19] and
thus serves as a perfect model to study the role of cataract causing
mutants of aA-crystallin in mammalian cells including the eye lens
cells. Compared to aA-wt, expression of all the mutants in these
cells showed significant increase in protein aggregation after 48
hours of transfection, R21L showing the least increase although
higher than the control aA-wt. It is likely that the protein
aggregation in the cytoplasm was due to protein conformational
changes the mutants undergo [11]. When these mutants were
expressed individually, they formed aggregates probably due to
stress in the absence of any protective mechanism such as the
presence of aB-crystallin, a powerful sHsp. sHsps, in general, can
inhibit protein aggregation and can reverse or refold aggregated
proteins in conjunction with Hsp 70, a major molecular
chaperone. As shown in an earlier study of the C-terminal
truncated aA-crystallins [19], association with native aA-crystallin
significantly increased the number of cells containing aggregates in
all mutants. These results suggest that aA-crystallin is not a
potential chaperone to protect the cells from protein aggregation.
It is interesting to note that most of the mutants of aA-crystallin
involve arginine residues and lead in a dominant fashion. Co-
expression with aB-crystallin, on the other hand, significantly
diminished the aggregation, R12C, R21L, R116C and R116H
showing the most effect and R49C and R54C showing the least
effect. aB-crystallin is known to be a better molecular chaperone
than aA-crystallin and as it has been shown earlier with C-
terminal truncated aA-crystallins [20], it readily recognizes
partially unfolded structures and prevent them from aggregation.
Also, this study provides the first evidence for cataract causing
mutants of aA-crystallin forming aggresomes in cells. Accumula-
tion of misfolded proteins results from saturation of protein
degradation system observed in conformational diseases like
Huntington disease [21] and cystic fibrosis [22] leading to the
formation of inclusion bodies also known as aggresomes. The
inclusion bodies concentrated in the perinuclear region of aA-
crystallin mutants expressed in HeLa cells suggests that they have
the characteristic features of aggresomes. They are cytoplasmic
globular structures formed due to protein misfolding in the cytosol
Figure 6. Degradation of aggregate-prone aA-crystallin mutant, R116C. A and C: Western blot analysis of cycloheximide treated cells: HeLa
cells were transfected with 2 mg of untagged pCDNA3.1 constructs of aA-wt and the mutant, R116C. After 24 h transfection, cells were treated with
20 mg/ml of cycloheximide and lysed with lysis buffer at indicated time points. For each of the sample, 5 mg of total protein was loaded and western
blot probed with an anti-aA-crystallin (rabbit polyclonal, Enzo Life Sciences Inc., Catalog # SPA-221). The mutant R116C protein level has decreased
after 6 hours treatment with cycloheximide compared to wild-type protein which demonstrated R116C protein instability. The b-Actin blot serves as a
loading control. B and D: Quantification of wild-type and the mutant, R116C protein at different time points. The density of the band was quantified
using NIH Image J software and plotted. Values represent as means 6 SD as obtained in three independent experiments. The mutant, R116C Vs wild-
type control is significant at p , 0.001.
doi:10.1371/journal.pone.0028085.g006
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center (MTOC) by retrograde transport along microtubules [12].
These aggresomes are not merely a storage site for misfolded
proteins; they can facilitate the degradation of protein aggregates [12]
and are the pathological hallmark of conformational diseases that
results from protein misfolding. In the present study, double
immunofluorescence results (Fig. 5) validate the co-localization of
aA-crystallin with a centrosome marker protein, c-tubulin, in
aggresomes. The c-tubulin has been previously shown to co-localize
with aggresomes in MTOC [23–25]. They are normally formed
when ubiquitin-proteasome degradation pathway is impaired and
disease-associated proteins inefficiently fold [26], [27]. Our findings
on aggresomes detection in cells transfected with aA-crystallin
mutants are very similar to the previous studies on a myopathy
causing mutant of human aB-crystallin, R120G, which forms
aggresomes in CCL39 cells [28]. Aggresomes are special protective
structures that fundamentally differ from other multiple aggregates,
that some of which cause cellular toxicity. They are formed around
MTOC, a sub-cellular region which is robustly enriched with
chaperones and components of UPS [12]. It has been reported that
multiple aggregates or pre-aggresome particles may be an interme-
diate step in aggresome formation which can proceed further upon
proteasome inhibition [15]. The present study documented both
multiple aggregates and typical perinuclear localized aggresomes.
Typical aggresomes were detected only in R116C mutant but not in
R21L, which suggest that the multiple aggregates in cells expressing
this mutant did not develop as aggresomes.
It has been suggested that unfolded proteins develop into
insoluble form that cannot be degraded, their sequestration in one
large mass may facilitate their removal by autophagy [23].
Degradation of C-terminal truncated aA-162 through ubiquitin-
proteasome pathway has been reported previously using recombi-
nant proteins [29]. Proteins with short half-lives are mostly
degraded by the proteasome [30]. Our results on the mutant-
R116C protein degradation upon cycloheximide treatment are
consistent with a previous report [31] on a truncated aB-crystallin,
450delA protein which has lower half-life [31]. The Ubiquitin-
Proteasome System (UPS) degrades short-lived nuclear, misfolded
cytosolic proteins extruded from the endoplasmic reticulum [16].
Substrates of UPS need to unfoldto pass through the narrow barrel-
Figure 7. Overexpression of aA-Crystallin mutants showed increased ubiquitination. A: Western blot analysis: After 48 h transfection, cells
were lysed and 5 mg of total protein was subjected to immunoblot probed with an anti-ubiquitin (FK2) monoclonal antibody. The pattern of
polyubiquitinated species were dramatically increased in the mutants, R21W, R116C and R116H compared to other mutants and wild-type. * indicates
a non-specific band. The same blot was stripped and re-probed for aA-crystallin and b-actin for loading controls. The blot shown here is a
representative blot of three independent experiments. B: Quantitative data for the western blot: Using NIH Image J software, densitometric
measurements were normalized against b-actin. The mutants, R21L, R21W, R116C and R116H showed increased ubiquitination as obtained in three
independent experiments and plotted. The results were expressed as mean 6 SD. The p value for aA-wt Vs aA-R12C is not significant, for aA-wt Vs
aA-R21L is , 0.05; for aA-wt Vs aA-R21W is , 0.01; for aA-wt Vs aA-R49C is not significant; for aA-wt Vs aA-R54C is not significant; for aA-wt Vs aA-
R116C is , 0.003 and for aA-wt Vs aA-R116H is , 0.001.
doi:10.1371/journal.pone.0028085.g007
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substrates for UPS [32], [33]. The pattern of ubiquitination as we
documented in overexpression of three mutants of aA-crystallin,
R21W, R116C and R116H suggest involvement of Ubiquitin
ProteasomePathway (UPP) inthe turnoverof ubiquitinated adducts
eventhough other cellularmachineries could alsobe engaged in this
event. Although there was a basic degradation pattern evident in
aA-wt buttheintensityof the degraded bands at 25 and37 kDawas
stronger in the mutants compared to aA-wt. From this perspective,
involvementofaA-crystallin inubiquitinationpathwaymayprovide
new insights into the etiology of congenital cataracts.
In summary, we have demonstrated overexpression of aA-
crystallin mutants forming small dispersed cytoplasmic aggregates
and aggresomes in HeLa cells. Co-expression of aB-wt signifi-
cantly inhibits aggregates caused by the aA mutants. The mutant
R116C has short half-life and degraded through ubiquitin-
proteasome pathway that may contribute to the development of
congenital cataract in human beings.
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Figure 8. Overexpression of aA-crystallin mutants shows
accumulation of ubiquitin inclusions in HeLa cells. YFP-tagged
aA-wt and mutant, R116C were transfected in HeLa cells. After 48 h
transfection, cells were fixed and immunostained with a mouse
monoclonal ubiquitin (FK2) antibody and further stained with a
fluorescent conjugated secondary antibody, Alexa Flour 594 (red). The
arrows indicate ubiquitinated cytoplasmic inclusions only in the
mutant, R116C expressing cells. Hoechst 33342 was used to counter
stain the nuclei. The images were representative of three similar images
obtained in three independent experiments.
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